TD Private Client Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.5K	Buy	59 +56	+1,867%	+$19.1K	﹤0.01%	1014
2025 Q4	$1.19K	Hold	3	–	–	﹤0.01%	1343
2025 Q3	$1.37K	Buy	3 +2	+200%	+$814	﹤0.01%	1290
2025 Q2	$326	Hold	1	–	–	﹤0.01%	1360
2025 Q1	$270	Buy	+1	New	+$257	﹤0.01%	1367
2023 Q3	–	Sell	-9	Closed	-$1.71K	–	1215
2023 Q2	$1.71K	Hold	9	–	–	﹤0.01%	1178
2023 Q1	$1.8K	Hold	9	–	–	﹤0.01%	1161
2022 Q4	$2.14K	Hold	9	–	–	﹤0.01%	1114
2022 Q3	$1.8K	Hold	9	–	–	﹤0.01%	1117
2022 Q2	$1.31K	Hold	9	–	–	﹤0.01%	1160
2022 Q1	$1.47K	Sell	9 -6	-40%	-$914	﹤0.01%	1188
2021 Q4	$2.54K	Sell	15 -18	-55%	-$3.35K	﹤0.01%	996
2021 Q3	$6.23K	Hold	33	–	–	﹤0.01%	944
2021 Q2	$5.59K	Hold	33	–	–	﹤0.01%	949
2021 Q1	$4.66K	Hold	33	–	–	﹤0.01%	934
2020 Q4	$4.29K	Sell	33 -45	-58%	-$6.01K	﹤0.01%	903
2020 Q3	$11.4K	Hold	78	–	–	﹤0.01%	780
2020 Q2	$11.6K	Hold	78	–	–	﹤0.01%	785
2020 Q1	$8.49K	Buy	78 +3	+4%	+$346	﹤0.01%	771
2019 Q4	$8.64K	Buy	+75	New	+$7.48K	﹤0.01%	768